UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052244
Receipt number R000059636
Scientific Title Cross-sectional observational study for the relationships between specific body condition and immune function in the healthy elderly subjects
Date of disclosure of the study information 2023/09/19
Last modified on 2025/03/28 09:45:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study for immune function in the healthy elderly subjects

Acronym

Study for the immune function in the elderly subjects

Scientific Title

Cross-sectional observational study for the relationships between specific body condition and immune function in the healthy elderly subjects

Scientific Title:Acronym

Cross-sectional observational study for the relationships between specific body condition and immune function in the elderly subjects

Region

Japan


Condition

Condition

None

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the relationship between specific body condition and immune function in the healthy elderly subjects.

Basic objectives2

Others

Basic objectives -Others

Observational study

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The ratio of specific immune cells

Key secondary outcomes

The ratio of other immune cells, Blood biochemistry test, Scoring of specific body condition, Subject's background questionnaire


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Male and Female more than 65 years old, when giving the informed consent.
2. Individuals not certified as Care/Support Need.
3. Individuals who were scored 0 or over 2 by the J-CHS criteria
4. Individuals who give the informed consents in writing, after receiving enough explanation of the purpose and details of the study, understanding the study well, and deciding to attend the study with their own will.
5. Individuals who can accomplish their tasks in the study at the appointed date
6. Individuals who are judged suitable for this study by the investigator.
7. Individuals who can understand Japanese

Key exclusion criteria

1. Individuals who are a patient of chronic disease such as diabetes, and mental illness such as Alzheimer's disease and dementia.
2. Individuals who are a patient of chronic inflammatory disease, autoimmune disease, cardiovascular disease, bowel disease, and immunologic disease.
3. Individuals who are a patient of or have a history of malignant.
4. Individuals who reject disclosing biological sex.
5. Individuals who intake alcohol drinks and exercise excessively on the test day and the day before the test day.
6. Individuals who have a smoking habit.
7. Individuals who are judged unsuitable for this study by the investigator for other reasons.

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Mitsuo
Middle name
Last name Maruyama

Organization

National Center for Geriatrics and Gerontology

Division name

GeroScience Research Center

Zip code

474-8511

Address

7-430, Morioka, Obu, Aichi

TEL

0562-46-2311

Email

michan@ncgg.go.jp


Public contact

Name of contact person

1st name keiko
Middle name
Last name Onishi

Organization

National Center for Geriatrics and Gerontology

Division name

GeroScience Research Center

Zip code

474-8511

Address

7-430, Morioka, Obu, Aichi

TEL

0562-46-2311

Homepage URL


Email

keiko-o@ncgg.go.jp


Sponsor or person

Institute

National Center for Geriatrics and Gerontology

Institute

Department

Personal name



Funding Source

Organization

Kirin Holdings Company, Limited

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics and Conflict of Interest Committee, National Center for Geriatrics and Gerontology

Address

7-430, Morioka, Obu, Aichi

Tel

0562-46-2311

Email

IRB@ncgg.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立研究開発法人 国立長寿医療研究センター(愛知県)


Other administrative information

Date of disclosure of the study information

2023 Year 09 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

141

Results

A relationship has been confirmed between aging and decreased immune function.

Results date posted

2025 Year 03 Month 26 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

1.Male and Female more than 65 years old, when giving the informed consent.
2.Individuals not certified as Care Need.

Participant flow


Adverse events

None

Outcome measures

・The ratio of specific immune cells
・Blood biochemistry test
・Scoring of specific body condition

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 06 Month 09 Day

Date of IRB

2023 Year 06 Month 09 Day

Anticipated trial start date

2023 Year 09 Month 19 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2023 Year 09 Month 19 Day

Last modified on

2025 Year 03 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059636